Letters Regarding Article by Mehilli et al, "Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel" * Response
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 31, 2005
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Abciximab (MeSH)
- Angioplasty, Balloon, Coronary (MeSH)
- Antibodies, Monoclonal (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Clinical Protocols (MeSH)
- Clopidogrel (MeSH)
- Coronary Restenosis (MeSH)
- Diabetic Angiopathies (MeSH)
- Dose-Response Relationship, Drug (MeSH)
- Graft Occlusion, Vascular (MeSH)
- Humans (MeSH)
- Immunoglobulin Fab Fragments (MeSH)
- Models, Statistical (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Stents (MeSH)
- Ticlopidine (MeSH)
published in
- Circulation Journal